In this video:
Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec Pharmalab
Topic: Sustainability as strategy: The next frontier for pharma leaders
Key Takeaways:
[1] ESG is no longer optional for the pharma industry. It is fundamental to survival, credibility and growth.
[2] Today, regulators like Securities and Exchange Board of India are mandating ESG disclosures through BRSR. Global frameworks are tightening.
[3] Investors are evaluating not just financial returns, but how responsibly those returns are generated. Customers and global buyers are increasingly choosing partners who are ethical, transparent and sustainable.